These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17442473)

  • 1. Buprenorphine substitution treatment in France: drug users' views of the doctor-user relationship.
    Guichard A; Lert F; Brodeur JM; Richard L
    Soc Sci Med; 2007 Jun; 64(12):2578-93. PubMed ID: 17442473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opiate substitution: the users' point of view].
    Chappard P
    Ann Pharm Fr; 2009 Sep; 67(5):365-8. PubMed ID: 19695373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. French general practitioners' attitudes and prescription patterns toward buprenorphine maintenance treatment: does doctor shopping reflect buprenorphine misuse?
    Feroni I; Peretti-Watel P; Paraponaris A; Masut A; Ronfle E; Mabriez JC; Obadia Y
    J Addict Dis; 2005; 24(3):7-22. PubMed ID: 16186080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
    Duburcq A; Charpak Y; Blin P; Madec L
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High dosage buprenorphine and injection practices. A study of 303 patients].
    Courty P
    Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S35-45. PubMed ID: 12910032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management.
    Roux P; Villes V; Blanche J; Bry D; Spire B; Feroni I; Carrieri MP
    Drug Alcohol Depend; 2008 Sep; 97(1-2):105-13. PubMed ID: 18479840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Questionnaire study of general practitioners regarding experience and attitude to opioid substitution therapy].
    Mravcík V; Coufalová M; Popov P; Zábranský T; Procházka R
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):27-33. PubMed ID: 15810140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reimbursement of opiate substitution drugs to militaries in 2007].
    d'Argouges F; Desjeux G; Marsan P; Thevenin-Garron V
    Encephale; 2012 Sep; 38(4):304-9. PubMed ID: 22980471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey.
    Nordmann S; Frauger E; Pauly V; Orléans V; Pradel V; Mallaret M; Thirion X; Micallef J
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):184-90. PubMed ID: 22109894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maintenance treatment with high-dose buprenorphine: are the recommendations being followed?].
    Seyer D; Dif C; Balthazard G; Sciortino V
    Therapie; 1998; 53(4):349-54. PubMed ID: 9806004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Buprenorphine for the treatment of opioid dependence: a study on generic substitution conducted in community pharmacies].
    Julians-Minou G; Bruch S; Peyre N; Sudérie G; Lapeyre-Mestre M; Roussin A
    Therapie; 2010; 65(3):241-7. PubMed ID: 20699077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-dose buprenorphine prescription in southern France from 1999 to 2001].
    Mancini J; Thirion X; Masut A; Ronflé E; Coudert C; Pradel V; Frauger E; Micallef J
    Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S7-14. PubMed ID: 12910029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of continuing medical education to reduce the risk of buprenorphine diversion.
    Lofwall MR; Wunsch MJ; Nuzzo PA; Walsh SL
    J Subst Abuse Treat; 2011 Oct; 41(3):321-9. PubMed ID: 21664789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.